This is due to aberrant signaling pathways in cancer cells that have effects on the loss of viral defense mechanisms, including the interferon (IFN), p53, and retinoblastoma (Rb) pathways and the induction of RAS/RAF/MEK/ERK pathways (11, 12). The gene discussed is TP53; the disease is cancer.